Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 22
Filter
1.
Oncogene ; 33(36): 4496-507, 2014 Sep 04.
Article in English | MEDLINE | ID: mdl-24608434

ABSTRACT

Metastasis is the predominant cause of death in breast cancer patients. Several lines of evidence have shown that microRNAs (miRs) can have an important role in cancer metastasis. Using isogenic pairs of low and high metastatic lines derived from a human breast cancer line, we have identified miR-149 to be a suppressor of breast cancer cell invasion and metastasis. We also identified GIT1 (G-protein-coupled receptor kinase-interacting protein 1) as a direct target of miR-149. Knockdown of GIT1 reduced migration/invasion and metastasis of highly invasive cells. Re-expression of GIT1 significantly rescued miR-149-mediated inhibition of cell migration/invasion and metastasis. Expression of miR-149 impaired fibronectin-induced focal adhesion formation and reduced phosphorylation of focal adhesion kinase and paxillin, which could be restored by re-expression of GIT1. Inhibition of GIT1 led to enhanced protein degradation of paxillin and α5ß1 integrin via proteasome and lysosome pathways, respectively. Moreover, we found that GIT1 depletion in metastatic breast cancer cells greatly reduced α5ß1-integrin-mediated cell adhesion to fibronectin and collagen. Low level of miR-149 and high level of GIT1 was significantly associated with advanced stages of breast cancer, as well as with lymph node metastasis. We conclude that miR-149 suppresses breast cancer cell migration/invasion and metastasis by targeting GIT1, suggesting potential applications of the miR-149-GIT1 pathway in clinical diagnosis and therapeutics.


Subject(s)
Adaptor Proteins, Signal Transducing/metabolism , Breast Neoplasms/pathology , Cell Cycle Proteins/metabolism , Integrins/metabolism , MicroRNAs/genetics , MicroRNAs/metabolism , Adaptor Proteins, Signal Transducing/genetics , Breast Neoplasms/metabolism , Cell Cycle Proteins/genetics , Female , Gene Expression Regulation, Neoplastic , Gene Knockdown Techniques , Humans , Integrins/genetics , Neoplasm Invasiveness/pathology , Neoplasm Metastasis/pathology , Signal Transduction , Tumor Cells, Cultured
2.
Oncogene ; 33(23): 2968-77, 2014 Jun 05.
Article in English | MEDLINE | ID: mdl-23851503

ABSTRACT

Gain of function of membrane receptor was a good strategy exploited by cancer cells to benefit own growth and survival. Overexpression of HER2 has been found to serve as a target for developing trastuzumab to treat 20-25% of breast cancer. However, little or none of the other membrane receptor was found to be useful as a potential target for breast cancer treatment since then. Here, we showed that amplified signaling of interleukin-17 receptor B (IL-17RB) and its ligand IL-17B promoted tumorigenicity in breast cancer cells and impeded acinus formation in immortalized normal mammary epithelial cells. External signal transmitted through IL-17RB activated nuclear factor-κB to upregulate antiapoptotic factor Bcl-2 and induced etoposide resistance. Elevated expression of IL-17RB had a stronger correlation with poor prognosis than HER2 in breast cancer patients. Interestingly, breast cancer patients with high expression of IL-17RB and HER2 had the shortest survival rate. Depletion of IL-17RB in trastuzumab-resistant breast cancer cells significantly reduced their tumorigenic activity, suggesting that IL-17RB and HER2 have an independent role in breast carcinogenesis. Furthermore, treatment with antibodies specifically against IL-17RB or IL-17B effectively attenuated tumorigenicity of breast cancer cells. These results suggest that the amplified IL-17RB/IL-17B signaling pathways may serve as a therapeutic target for developing treatment to manage IL-17RB-associated breast cancer.


Subject(s)
Breast Neoplasms/pathology , Carcinogenesis , NF-kappa B/metabolism , Receptors, Interleukin-17/antagonists & inhibitors , Receptors, Interleukin-17/metabolism , Animals , Apoptosis/drug effects , Autocrine Communication , Breast Neoplasms/metabolism , Carcinogenesis/drug effects , Cell Line, Tumor , Etoposide/pharmacology , Female , Gene Expression Regulation, Neoplastic , Humans , Interleukin-17/immunology , Interleukin-17/metabolism , MCF-7 Cells , Mammary Neoplasms, Experimental , Mice , Mice, Inbred NOD , Mice, SCID , NF-kappa B/antagonists & inhibitors , Paracrine Communication , Receptor, ErbB-2/metabolism , Signal Transduction/drug effects , Xenograft Model Antitumor Assays
3.
Int J Impot Res ; 24(4): 141-6, 2012.
Article in English | MEDLINE | ID: mdl-22495625

ABSTRACT

The overall prevalence of metabolic syndrome (MS) in aboriginal male Taiwanese is very high. Many studies have found that those with cardiovascular disease and MS have a significantly higher risk of ED. In this study, we attempted to find the correlation among MS risk factor, atherosclerosis risk factors and low serum testosterone in relation to the development of ED. This was a cross-sectional study of 238 cases, and collected data included demographic data, lifestyle questionnaires, sexual desire scale, sexual satisfaction scale and International Index of Erectile Function (IIEF) questionnaire. Among our 238 subjects, 146 had MS (61.3%) and 114 subjects with MS had ED (85.7%). Using age-adjusted multivariate logistic regressive analysis, this study showed that aboriginal males with ED had a significantly higher prevalence of MS (OR=12.02, 95% confidence intervals (CI): 6.33-22.83, P<0.001). Among the MS components, abnormal fasting blood sugar was the most significantly independent factor for ED in aboriginal males (OR=8.94, 95% CI: 4.71-16.97, P<0.001). The presence of MS had a significant correlation with lower IIEF-5 scores, lower sexual desire scores, lower testosterone serum level (P<0.01) and abnormal interleukin-6 (IL-6) and high sensitivity C-reactive protein (HsCRP). The results of this study support the idea that MS, low serum testosterone and HsCRP may predict ED in aboriginal Taiwanese males. Further studies with population-based and longitudinal design should be conducted to confirm this finding and design to compare rates of ED in aboriginal men with MS.


Subject(s)
Atherosclerosis/complications , Erectile Dysfunction/etiology , Gonadal Steroid Hormones/blood , Metabolic Syndrome/complications , Age Factors , Blood Glucose/analysis , C-Reactive Protein/analysis , Educational Status , Erectile Dysfunction/blood , Erectile Dysfunction/epidemiology , Fasting , Humans , Interleukin-6/blood , Male , Metabolic Syndrome/epidemiology , Risk Factors , Sexual Behavior , Surveys and Questionnaires , Taiwan/epidemiology , Testosterone/blood
4.
Breast Cancer Res Treat ; 130(1): 345-51, 2011 Nov.
Article in English | MEDLINE | ID: mdl-21792625

ABSTRACT

Metaplastic carcinoma of the breast (MCB) is a rare subtype of breast cancer. Anecdotal reports are available regarding its response to systemic chemotherapy. We reviewed the records of patients diagnosed with MCB at National Taiwan University Hospital between 1988 and 2009. A total of 46 MCB cases were identified from 8,695 breast tumor patients who underwent biopsy or resection. About 11 of 25 patients with initial bulky disease (T3-4) received neoadjuvant chemotherapy before surgery, and 2 (18.2%) exhibited a partial response. About 12 of 18 patients who developed distant metastasis received palliative systemic chemotherapy. Of them, only 1 (8.3%), 1 (10%), and none (0%) responded to first-, second-, or third- and beyond line chemotherapy, respectively. None of the patients who received anthracyline- (n = 13), vinorelbine- (n = 7), or cyclophosphamide-based (n = 18) chemotherapy responded, whereas 3 (17.6%) of 17 patients who received taxane-based chemotherapy exhibited a partial response. Tumor response to systemic chemotherapy remains generally poor for MCB patients. Taxanes may have modest activity, but need to be validated in further studies.


Subject(s)
Antineoplastic Combined Chemotherapy Protocols/therapeutic use , Breast Neoplasms/drug therapy , Carcinoma/drug therapy , Adult , Aged , Aged, 80 and over , Antineoplastic Agents/administration & dosage , Breast Neoplasms/pathology , Carcinoma/pathology , Female , Humans , Male , Middle Aged , Neoadjuvant Therapy , Neoplasm Staging , Palliative Care , Prognosis , Treatment Outcome
5.
Oncogene ; 30(21): 2463-74, 2011 May 26.
Article in English | MEDLINE | ID: mdl-21258409

ABSTRACT

MicroRNAs (miRNAs) are involved in tumorigenecity by regulating specific oncogenes and tumor suppressor genes, and their roles in breast cancer stem cells (BCSCs) are becoming apparent. Distinct from the CD44(+)/CD24(-/low) sub-population, we have isolated a novel PROCR(+)/ESA(+) BCSC sub-population. To explore miRNA-regulatory mechanisms in this sub-population, we performed miRNA expression profiling and found miR-495 as the most highly upegulated miRNA in PROCR(+)/ESA(+) cells. Coincidently, high upregulation of miR-495 was also found in CD44(+)/CD24(-/low) BCSCs, reflecting its potential importance in maintaining common BCSC properties. Ectopic expression of miR-495 in breast cancer cells promoted their colony formation in vitro and tumorigenesis in mice. miR-495 directly suppressed E-cadherin expression to promote cell invasion and inhibited REDD1 expression to enhance cell proliferation in hypoxia through post-transcriptional mechanism. miR-495 expression was directly modulated by transcription factor E12/E47, which itself is highly expressed in BCSCs. These findings reveal a novel regulatory pathway centered on miR-495 that contributes to BCSC properties and hypoxia resistance.


Subject(s)
Cadherins/genetics , MicroRNAs/genetics , Neoplastic Stem Cells/metabolism , Transcription Factor 3/genetics , Transcription Factors/genetics , Animals , Base Sequence , Breast Neoplasms/genetics , Breast Neoplasms/metabolism , Breast Neoplasms/pathology , Cadherins/metabolism , Cell Hypoxia , Cell Line , Cell Line, Tumor , Down-Regulation , Female , Gene Expression Profiling , HEK293 Cells , Humans , Immunoblotting , Mammary Neoplasms, Experimental/genetics , Mammary Neoplasms, Experimental/metabolism , Mammary Neoplasms, Experimental/pathology , Mice , Mice, Inbred NOD , Mice, SCID , Molecular Sequence Data , Promoter Regions, Genetic/genetics , Protein Binding , Reverse Transcriptase Polymerase Chain Reaction , Transcription Factor 3/metabolism , Transcription Factors/metabolism , Transplantation, Heterologous
6.
Br J Cancer ; 100(4): 563-70, 2009 Feb 24.
Article in English | MEDLINE | ID: mdl-19190627

ABSTRACT

As the epidemiological pattern of breast cancer in modernising Asian countries differs greatly from that in Western countries, it is worthwhile to investigate the long-term prognoses of unilateral and bilateral breast cancer in these nations. A retrospective cohort study composed of 1907 Taiwanese women was conducted to follow 1863 unilateral and 44 bilateral cases of breast cancer. Time-dependent Cox regression was used to assess the risk of breast cancer death by considering the time course of unilateral and bilateral tumour development. The 15-year survival rates were 68.37, 62.63, and 26.42% for unilateral, synchronous bilateral, and metachronous bilateral breast cancer, respectively. Differences among types were most apparent after 5 years of follow-up. After adjusting for significant prognostic factors, the risk of death for overall bilateral breast cancer was 2.50-fold greater (95% CI, 1.43-4.37) compared to unilateral breast cancer. The corresponding figures were 1.12-fold (95% CI, 0.42-3.02) and 6.11-fold (95% CI, 3.14-11.89) for synchronous and metachronous bilateral breast cancer, respectively. Taiwanese women, who are frequently diagnosed with breast cancer before 50 years of age, showed poorer survival for metachronous bilateral than for synchronous bilateral or unilateral breast cancer. Survival was markedly poorer compared to recent data from Sweden.


Subject(s)
Breast Neoplasms/mortality , Breast Neoplasms/pathology , Adult , Age of Onset , Breast Neoplasms/diagnosis , Breast Neoplasms/epidemiology , Cohort Studies , Female , Humans , Middle Aged , Prognosis , Retrospective Studies , Survival Rate , Taiwan/epidemiology
7.
Oncogene ; 26(57): 7859-71, 2007 Dec 13.
Article in English | MEDLINE | ID: mdl-17603561

ABSTRACT

Metaplastic carcinoma of the breast (MCB) is a poorly understood subtype of breast cancer. It is generally characterized by the coexistence of ductal carcinomatous and transdifferentiated sarcomatous components, but the underlying molecular alterations, possibly related to epithelial-mesenchymal transition (EMT), remain elusive. We performed transcriptional profiling using half-a-genome oligonucleotide microarrays to elucidate genetic profiles of MCBs and their differences to those of ductal carcinoma of breasts (DCBs) using discarded specimens of four MCBs and 34 DCBs. Unsupervised clustering disclosed distinctive expression profiles between MCBs and DCBs. Supervised analysis identified gene signatures discriminating MCBs from DCBs and between MCB subclasses. Notably, many of the discriminator genes were associated with downregulation of epithelial phenotypes and with synthesis, remodeling and adhesion of extracellular matrix, with some of them have known or inferred roles related to EMT. Importantly, several of the discriminator genes were upregulated in a mutant Snail-transfected MCF7 cell known to exhibit features of EMT, thereby indicating a crucial role for EMT in the pathogenesis of MCBs. Finally, the identification of SPARC and vimentin as poor prognostic factors reinforced the role of EMT in cancer progression. These data advance our understanding of MCB and offer clues to the molecular alterations underlying EMT.


Subject(s)
Breast Neoplasms/genetics , Carcinoma, Ductal, Breast/genetics , Cell Transformation, Neoplastic , Epithelium/pathology , Gene Expression Profiling , Mesoderm/pathology , Sarcoma/genetics , Breast Neoplasms/pathology , Carcinoma, Ductal, Breast/pathology , Cell Line, Tumor , Female , Gene Expression Regulation, Neoplastic , Humans , Multigene Family , Oligonucleotide Array Sequence Analysis , Prognosis , Receptors, Estrogen/analysis , Receptors, Progesterone/analysis , Sarcoma/pathology , Snail Family Transcription Factors , Transcription Factors/physiology
8.
Cell Mol Life Sci ; 61(19-20): 2597-613, 2004 Oct.
Article in English | MEDLINE | ID: mdl-15526165

ABSTRACT

Early studies of the inhibitor of growth 1 ( ING1) gene, the founding member of the ING tumor suppressor family, demonstrated that this gene plays an important role in apoptosis and cellular senescence. Four other related genes have since been identified and found to be involved in various biological activities, including cell cycle arrest, regulation of gene transcription, DNA repair and apoptosis. The biochemical functions of ING proteins as histone acetyltransferases and histone deacetylase co-factors ties this new tumor suppressor family to the regulation of transcription, cell cycle check-points, DNA repair and apoptosis. This review is aimed at summarizing the known biological functions of the ING tumor suppressors and the signalling pathways that they involve.


Subject(s)
Apoptosis , Proteins/physiology , Acetylation , Animals , Cell Cycle , Cell Cycle Proteins , Cell Line, Tumor , Cellular Senescence , DNA Repair , DNA-Binding Proteins , Genes, Tumor Suppressor , Histones/metabolism , Humans , Inhibitor of Growth Protein 1 , Intracellular Signaling Peptides and Proteins , Models, Biological , Models, Genetic , Mutation , Nuclear Proteins , Phosphatidylinositols/chemistry , Protein Structure, Tertiary , Transcription, Genetic , Tumor Suppressor Protein p53/metabolism , Tumor Suppressor Proteins
10.
Psychol Med ; 31(7): 1181-91, 2001 Oct.
Article in English | MEDLINE | ID: mdl-11681544

ABSTRACT

BACKGROUND: Utilizing a prospectively designed community sample, we set out to estimate the rate of newly-incident suicidal ideation and attempts (non-fatal suicide behaviour) in a community sample, to evaluate antecedent sociodemographic characteristics and psychiatric disorders, and to assess use of mental health services in relation to non-fatal suicide behaviour. METHOD: Prospectively-gathered data was utilized from 3481 continuing participants in the 13-year follow-up of the Baltimore sample of the NIMH Epidemiologic Catchment Area survey interviewed in 1981, 1982 and 1993/6. RESULTS: The incidence of suicide attempts was estimated at 148.8 per 100,000 person-years and ideation at 419.9 per 100,000 person-years. Persons in the youngest age group, in the lowest socioeconomic status, and previously married persons were at increased risk for non-fatal suicide behaviour during the follow-up interval. Persons who reported suicidal ideation at baseline were more likely to report having attempted suicide at follow-up (RR = 6.09, 95% CI 2.58-14.36). Psychiatric disorders, especially depression and substance abuse, were associated with new-onset of non-fatal suicidal behaviour. While persons who reported newly-incident suicidal behaviour were more likely to report use of mental health services, few said that suicidal ideation or attempts were the reason for the visits. CONCLUSIONS: Suicidal ideation is a common and important antecedent to suicide attempts and deserves more attention in community and general medical settings.


Subject(s)
Suicide, Attempted/statistics & numerical data , Adolescent , Adult , Aged , Baltimore/epidemiology , Catchment Area, Health , Female , Follow-Up Studies , Humans , Incidence , Male , Maryland/epidemiology , Mental Health Services/statistics & numerical data , Middle Aged , Prospective Studies , Surveys and Questionnaires
11.
Clin Chim Acta ; 294(1-2): 157-68, 2000 Apr.
Article in English | MEDLINE | ID: mdl-10727681

ABSTRACT

To examine the possible involvement of MMP-9 and -2 in the development of liver diseases caused by HCV or HBV infection, serum activities of both enzymes were studied by zymograph. Eight groups of subjects (60 for each) were examined in the study: healthy control, patients with hepatoma, liver cirrhosis, chronic hepatitis B or chronic hepatitis C, and carriers positive for HBsAg, both HBsAg and HBeAg, or anti-HCV. The results showed significant changes in the MMP-9 and -2 activities in the carriers. The presence of HBeAg was accompanied by a highest activity of MMP-2 and an inversely correlated (r=-0.578, P=<0.001), lowest activity of MMP-9 among all groups. For those with active liver diseases, MMPs activities were fluctuated at each stage of pathological symptoms. Chronic hepatitis B and C patients had significant different serum MMP-2 and -9 activities. These findings imply an influence on the balance of MMPs system by the existence of virus that might influence the following progression of liver disease, and a distinction between the pathological mechanisms of HCV and HBV. Since the serum MMPs activities were significantly varied between each stage of liver disease, an individual profile of these parameters might serve as an easy accessing serum marker to monitor the progression of liver disease.


Subject(s)
Carrier State/blood , Hepatitis B, Chronic/blood , Hepatitis C, Chronic/blood , Matrix Metalloproteinase 2/blood , Matrix Metalloproteinase 9/blood , Alanine Transaminase/blood , Analysis of Variance , Aspartate Aminotransferases/blood , Biomarkers/blood , Carcinoma, Hepatocellular/blood , Carcinoma, Hepatocellular/enzymology , Carrier State/enzymology , Hepatitis B Surface Antigens/blood , Hepatitis B e Antigens/blood , Hepatitis B, Chronic/enzymology , Hepatitis C Antibodies/blood , Hepatitis C, Chronic/enzymology , Liver Cirrhosis/blood , Liver Cirrhosis/enzymology , Liver Neoplasms/blood , Liver Neoplasms/enzymology , Reference Values
12.
Gastrointest Endosc ; 49(5): 627-31, 1999 May.
Article in English | MEDLINE | ID: mdl-10228263

ABSTRACT

BACKGROUND: Cryotherapy or the application of extreme cold has many potential applications in gastroenterology including tissue destruction and hemostasis but until now its development has been prevented by the lack of a delivery device suitable for use through the endoscope. We report here our experience with prototype devices using both liquid nitrogen driven by a cryosurgical system and cryogenic refrigerants (nitrous oxide and carbon dioxide) at or near ambient temperature. METHODS: Cryotherapy was applied to the distal esophageal mucosa of dogs via a flexible catheter passed through an upper endoscope. In other dogs, cryotherapy was used for hemostasis in a bleeding ulcer model. The procedure was also used for palliation in a 58-year-old man with unresectable adenocarcinoma of the stomach with pyloric channel obstruction. RESULTS: Freezing of the superficial mucosa was nearly instantaneous. All dogs survived the procedure and appeared to thrive. Histologic evaluation revealed significant necrosis of the superficial epithelial layer accompanied by a fibrinocellular infiltrate on the surface. These markers of acute injury subside by the fourth to sixth day and are replaced by regenerating epithelium, a process that is virtually complete by day 10. In the hemostasis experiments, bleeding ceased immediately after cryospraying of the lesions but resumed on thawing in most cases. Application of cryotherapy in the patient resulted in reduction of the pyloric mass with no immediately apparent adverse effects. CONCLUSIONS: These data, although preliminary, demonstrate the feasibility of endoscopic cryotherapy using a simple hand-held device. This device has broad potential for use in gastroenterology including ablation of superficial epithelium, debulking of large tumors and hemostasis.


Subject(s)
Cryotherapy/methods , Endoscopy, Gastrointestinal/methods , Adenocarcinoma/therapy , Animals , Cryotherapy/instrumentation , Disease Models, Animal , Dogs , Endoscopes, Gastrointestinal , Equipment Design , Esophagus/pathology , Fatal Outcome , Humans , Male , Middle Aged , Mucous Membrane/pathology , Peptic Ulcer Hemorrhage/therapy , Pylorus , Stomach Neoplasms/therapy , Stomach Ulcer/complications , Stomach Ulcer/therapy
13.
Dig Dis Sci ; 43(8): 1690-4, 1998 Aug.
Article in English | MEDLINE | ID: mdl-9724153

ABSTRACT

Gastroparesis is a common debilitating complication in many diabetic patients. While several drugs are available for gastroparesis, many patients are not adequately treated. Many patients do not respond to available drugs or appear to develop tachyphylaxis after an initial response. New agents are needed. Erythromycin is a macrolide antibiotic that accelerates gastric emptying through interaction with motilin receptors. Many antibiotics, like erythromycin itself, have significant gastrointestinal side effects. We investigated the ability of cephalosporin antibiotics to alter gastric emptying in mice by employing phenol red spectrophotometry to monitor gastric emptying. Our results indicate that several cephalosporin antibiotics, particularly cefazolin, accelerate gastric emptying. In some cases these drugs appear more efficacious than either erythromycin or metoclopramide. At very high doses, many drugs, including erythromycin, appear to delay gastric emptying. We hypothesize that the gastrointestinal side effects of nausea and vomiting may result from delayed gastric emptying occurring at high doses while lower doses are prokinetic in the stomach.


Subject(s)
Anti-Bacterial Agents/pharmacology , Cephalosporins/pharmacology , Gastric Emptying/drug effects , Animals , Erythromycin/pharmacology , Male , Mice , Mice, Inbred C57BL
14.
Gastrointest Endosc Clin N Am ; 8(2): 273-81, 1998 Apr.
Article in English | MEDLINE | ID: mdl-9583006

ABSTRACT

Gastroesophageal reflux disease (GERD) is the most common cause of esophageal strictures, accounting for approximately 70% of all cases. Reflux strictures of the esophagus are serious complications of GERD and are associated with a high relapse rate. Goals of long-term management include the relief of dysphagia, prevention of stricture recurrence, and avoidance of complications with safe, cost-effective therapy. Despite recent advances in knowledge about GERD, reflux stricture still remains a relatively common and challenging clinical problem.


Subject(s)
Esophageal Stenosis/etiology , Esophageal Stenosis/therapy , Gastroesophageal Reflux/complications , Dilatation/adverse effects , Dilatation/methods , Esophageal Stenosis/physiopathology , Esophagoscopy , Humans , Steroids/therapeutic use
15.
J Formos Med Assoc ; 97(2): 127-30, 1998 Feb.
Article in English | MEDLINE | ID: mdl-9509849

ABSTRACT

Laparoscopic surgery is rapidly gaining in popularity among general surgeons. It is not widely used to treat abdominal malignancies because of technical difficulties and the fear of peritoneal dissemination. We describe the use of laparoscopic surgery to treat early gastric cancer. A 66-year-old man was diagnosed with early gastric adenocarcinoma by endoscopic ultrasonography and biopsy. Subtotal gastrectomy along with removal of the perigastric (D1) and selective extraperigastric lymph nodes over the celiac trunk was accomplished laparoscopically, through five punctures and a minilaparotomy. The patient's convalescence was uneventful. Bowel sounds were heard on postoperative day 1. On postoperative day 3, he passed flatus. The patient was started on a clear liquid diet on postoperative day 5. There was neither leakage nor obstruction after oral intake. He was discharged on postoperative day 11. No local recurrence or distant metastasis was found during 16 months' follow-up. This is the first report of successful laparoscopic resection of early gastric cancer with lymph node dissection in Taiwan.


Subject(s)
Gastrectomy , Laparoscopy , Lymph Node Excision , Stomach Neoplasms/surgery , Aged , Humans , Male , Stomach Neoplasms/pathology
16.
Gastrointest Endosc Clin N Am ; 8(1): 79-85, 1998 Jan.
Article in English | MEDLINE | ID: mdl-9405752

ABSTRACT

Endoscopic manometry of the sphincter of Oddi (SO) is now an accepted technique in the diagnosis and therapy of biliary disease. Its role in the evaluation of pancreatic sphincter function for pancreatic diseases, however, is evolving. There are now preliminary data to suggest that pancreatic SO manometry may identify a subgroup of patients with pancreatic sphincter dysfunction that may benefit from endoscopic therapy. Further prospective clinical trials are sorely needed to evaluate the response of endoscopic therapy based on pancreatic SO basal pressure or pancreatic ductal pressure.


Subject(s)
Manometry , Pancreatic Diseases/diagnosis , Sphincter of Oddi/physiopathology , Cholangiopancreatography, Endoscopic Retrograde , Chronic Disease , Endoscopy, Digestive System , Humans , Pancreatic Diseases/physiopathology , Pancreatic Diseases/therapy , Pancreatitis/diagnosis , Pancreatitis/physiopathology
17.
Genetics ; 113(4): 985-1007, 1986 Aug.
Article in English | MEDLINE | ID: mdl-3091450

ABSTRACT

Results of immunogenetic, immunochemical and physicochemical investigations on two serum allotypes of swine are reported. The allotypes, designated Lpr1 and Lpr2, have been identified by specific alloprecipitins in agar gel. Genetic studies indicate that the allotypes are specified by two codominant autosomal allelic genes, Lpr1 and Lpr2. All pigs 3 months of age or older were classified as belonging to one of three phenotypes, Lpr1, Lpr2 or Lpr1,2, each corresponding to one of three genotypes Lpr1/1, Lpr2/2 or Lpr1/2, respectively. The Lpr1 gene was absent or was found at low frequency in the breeds tested. The allotypes were found to occur in two physicochemical forms; in association with chylomicrons and very low density lipoproteins (VLDL) and, primarily, as a Lpr multimer free of the major lipoproteins showing very high density (VHD), d greater than 1.21 g/ml, and MW +/- 190,000. Gel-electrophoretic mobility for VHD-Lpr is different for each of the three Lpr genotypes residing in gamma-fast and beta-slow regions, but is identical for VLD-Lpr in which Lpr was found complexed with apo-B, migrating as VLDL in the alpha-2 slow (pre-beta) region. Serum levels of Lpr varied during the lifetime and between individuals and, especially, between sera of homozygous pigs being higher in Lpr1/1 than Lpr2/2. A linear relationship for Lpr1 and an atypical, inverse relationship for Lpr2 have been observed between the gene dosage, heterozygous vs. homozygous, and the Lpr serum level.


Subject(s)
Lipoproteins/genetics , Polymorphism, Genetic , Animals , Antigen-Antibody Complex , Chromatography, Gel , Gene Frequency , Genes , Immune Sera , Immunodiffusion , Immunoelectrophoresis , Lipoproteins/blood , Lipoproteins/immunology , Phenotype , Swine
19.
J Nerv Ment Dis ; 172(8): 449-57, 1984 Aug.
Article in English | MEDLINE | ID: mdl-6747614

ABSTRACT

The dearth of population-based studies and epidemiological investigations on the mental health problems of Asian-Americans, especially since the change in the immigration laws in 1965, has led to contradictory speculations about the prevalence rates of mental illness and the general mental health status among Asian-Americans, as opposed to other segments of the population. We administered the Center for Epidemiologic Studies Depression (CES-D) scale to 499 samples drawn from a Northwestern coastal city in order to make an initial assessment of the amount of depression experienced by Asian-Americans. The investigation compared the Asian-Americans' CES-D scores with those of whites and other minority groups, examined the scale's patterns of factor loading by ethnicity, and discovered that, even with statistical controls, there exists a distinction among the individual groups of Chinese, Filipinos, Japanese, and Koreans with respect to their score averages of depressive symptoms.


Subject(s)
Asian , Depressive Disorder/epidemiology , Adolescent , Adult , Age Factors , China/ethnology , Depressive Disorder/diagnosis , Depressive Disorder/psychology , Emigration and Immigration , Employment , Female , Humans , Japan/ethnology , Korea/ethnology , Male , Middle Aged , Philippines/ethnology , Psychiatric Status Rating Scales , Sex Factors , Social Adjustment , Washington
SELECTION OF CITATIONS
SEARCH DETAIL
...